BR9609153A - Derivados de estiril-benzimidazol como inibidores da proliferação de celula de musculo liso - Google Patents

Derivados de estiril-benzimidazol como inibidores da proliferação de celula de musculo liso

Info

Publication number
BR9609153A
BR9609153A BR9609153A BR9609153A BR9609153A BR 9609153 A BR9609153 A BR 9609153A BR 9609153 A BR9609153 A BR 9609153A BR 9609153 A BR9609153 A BR 9609153A BR 9609153 A BR9609153 A BR 9609153A
Authority
BR
Brazil
Prior art keywords
inhibitors
styrene
cell proliferation
smooth muscle
muscle cell
Prior art date
Application number
BR9609153A
Other languages
English (en)
Inventor
Sie-Yearl Chai
Hassan Mahmoud Elokdah
Theodore Sylvesteer Sulkowski
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9609153A publication Critical patent/BR9609153A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9609153A 1995-06-06 1996-06-03 Derivados de estiril-benzimidazol como inibidores da proliferação de celula de musculo liso BR9609153A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/468,271 US6444694B1 (en) 1995-06-06 1995-06-06 Styryl benzimidazole derivatives
PCT/US1996/008375 WO1996039391A1 (en) 1995-06-06 1996-06-03 Styryl benzimidazole derivatives as inhibitors of smooth muscle cell proliferation

Publications (1)

Publication Number Publication Date
BR9609153A true BR9609153A (pt) 1999-05-04

Family

ID=23859136

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9609153A BR9609153A (pt) 1995-06-06 1996-06-03 Derivados de estiril-benzimidazol como inibidores da proliferação de celula de musculo liso

Country Status (19)

Country Link
US (1) US6444694B1 (pt)
EP (1) EP0830345B1 (pt)
JP (1) JPH11506753A (pt)
KR (1) KR19990022266A (pt)
CN (1) CN1192206A (pt)
AR (1) AR002749A1 (pt)
AT (1) ATE205196T1 (pt)
AU (1) AU711965B2 (pt)
BR (1) BR9609153A (pt)
CA (1) CA2223585A1 (pt)
DE (1) DE69615023T2 (pt)
DK (1) DK0830345T3 (pt)
ES (1) ES2162063T3 (pt)
HU (2) HUP9900914A2 (pt)
IL (1) IL118385A0 (pt)
NZ (1) NZ309499A (pt)
PT (1) PT830345E (pt)
WO (1) WO1996039391A1 (pt)
ZA (1) ZA964693B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
EP2335700A1 (en) 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
US7098231B2 (en) 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
DK1718608T3 (da) 2004-02-20 2013-10-14 Boehringer Ingelheim Int Virale polymeraseinhibitorer
CA2618682C (en) 2005-08-12 2011-06-21 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
EP2035369B1 (en) 2006-07-05 2014-06-25 Fibrotech Therapeutics PTY LTD Therapeutic compounds
WO2011047432A1 (en) * 2009-10-22 2011-04-28 Fibrotech Therapeutics Pty Ltd Fused ring analogues of anti-fibrotic agents
WO2018144620A1 (en) 2017-02-03 2018-08-09 Shire Human Genetic Therapies, Inc. Anti-fibrotic compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3575956A (en) * 1967-07-24 1971-04-20 Sterling Drug Inc 2-substituted-benz-x-azol-6-ylazo-aminonaphthalene compounds
DE1670908A1 (de) * 1967-08-16 1971-04-29 Hoechst Ag Neue Benzimidazolverbindungen,Verfahren zu ihrer Herstellung und ihre Verwendung als optische Aufhellungsmittel
FR2104717A1 (en) * 1970-09-28 1972-04-21 Dynachim Sarl Organophosphorus pesticides stabilised with benzimidazole derivs - - for controlling insects and internal parasites of animals
DE3505609A1 (de) 1985-02-19 1986-08-21 Merck Patent Gmbh, 6100 Darmstadt Benzimidazolyl-pyridazinone
JPH05507072A (ja) 1990-04-16 1993-10-14 イッスム　リサーチ　ディヴェロプメント　カンパニー　オブ　ザ　ヒーブルー　ユニヴァーシティ　オブ　エルサレム Ｅｇｆレセプタチロシンキナーゼを阻害する複素環式エテンジイル化合物
US5196446A (en) 1990-04-16 1993-03-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Certain indole compounds which inhibit EGF receptor tyrosine kinase
DE4212748A1 (de) 1992-04-16 1993-10-21 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5387600A (en) 1992-07-30 1995-02-07 Fuji Photo Film Co., Ltd. Treating arteriosclerosis using benzimidazole compositions

Also Published As

Publication number Publication date
MX9709647A (es) 1998-07-31
HUP9900914A2 (hu) 1999-07-28
DE69615023T2 (de) 2002-06-06
PT830345E (pt) 2002-01-30
AU5968496A (en) 1996-12-24
CA2223585A1 (en) 1996-12-12
DK0830345T3 (da) 2001-11-19
AR002749A1 (es) 1998-04-29
EP0830345A1 (en) 1998-03-25
DE69615023D1 (de) 2001-10-11
HUP9900679A3 (en) 2001-07-30
HUP9900679A2 (hu) 1999-09-28
EP0830345B1 (en) 2001-09-05
ZA964693B (en) 1997-12-05
WO1996039391A1 (en) 1996-12-12
KR19990022266A (ko) 1999-03-25
ES2162063T3 (es) 2001-12-16
AU711965B2 (en) 1999-10-28
IL118385A0 (en) 1996-09-12
CN1192206A (zh) 1998-09-02
ATE205196T1 (de) 2001-09-15
JPH11506753A (ja) 1999-06-15
NZ309499A (en) 2000-08-25
US6444694B1 (en) 2002-09-03

Similar Documents

Publication Publication Date Title
PT1150746E (pt) A utilizacao de derivados de 4-h-1-benzopiran-4-ona como inibidores da proliferacao celular do musculo liso
DE69637328D1 (de) Zelladhäsionsinhibitoren
PT946512E (pt) Derivados de 6-fenilpiridil-2-amina uteis como inibidores de nos
DE69635932D1 (de) Einheitliche orthopädische stütze
FI951001A0 (fi) Sulfatoituja alfa-glykolipidijohdannaisia soluadheesioinhibiittoreina
ATE228135T1 (de) Rapamycinderivate
DK1181269T3 (da) Celleproliferationsinhibitorer
PT956294E (pt) Inibidores da trombina
PT907358E (pt) Terapia de distribuicao uniforme de droga
MA24417A1 (fr) Comprime detrgent enrobe
PT891362E (pt) Derivados de pirrolopirrolona como inibidores da elastase dos neutrofilos
PT934280E (pt) Derivados 2-cianoiminoimidazolo inibidores da pde iv
PT892796E (pt) Derivados de isatina como inibidores de acetilcolinesterase e analgesicos
BR9609153A (pt) Derivados de estiril-benzimidazol como inibidores da proliferação de celula de musculo liso
BR9609311A (pt) Derivados de benzimidazol substituídos na posição 2 como inibidores de proliferação de células de músculo liso
PT835244E (pt) Acrilonitrilos di-heterociclicos como inibidores da proliferacao de celulas de musculo liso
PT830344E (pt) Derivados de benzimidazole 2-substituido como inibidores da proliferacao de celulas musculares lisas
BR9609365A (pt) Derivados de benzimidazol como inibidores de proliferação de células de músculo liso
PT1066284E (pt) Derivados de benzo [c] quinolizina e sua utilizacao como inibidores de 5-alfa-redutases
BR9609723A (pt) Derivados da tricetona
PT948483E (pt) Inibidores da farnesil-transferase
NO975811D0 (no) Ny anvendelse for pyrrolderivater
BR9612370A (pt) Sílica trata com uma geléia oleosapolimérica e uso da sílica
PT920330E (pt) Hcg e derivados como inibidores de metaloproteases de matriz
PL343872A1 (en) (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]